FDA Urges Infant Formula Industry to Improve Safety of Manufacturing Processes After Similac Recall
The FDA has issued a number of letters to the infant formula manufacturing industry in recent months, warning about safety violations and urging companies to inform the agency of any potential baby food contamination.